<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2448-8909</journal-id>
<journal-title><![CDATA[Medicina crítica (Colegio Mexicano de Medicina Crítica)]]></journal-title>
<abbrev-journal-title><![CDATA[Med. crít. (Col. Mex. Med. Crít.)]]></abbrev-journal-title>
<issn>2448-8909</issn>
<publisher>
<publisher-name><![CDATA[Colegio Mexicano de Medicina Crítica A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2448-89092024000700594</article-id>
<article-id pub-id-type="doi">10.35366/119534</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Asociación del índice leucoglucémico con la falla orgánica múltiple en pacientes sépticos en la Unidad de Cuidados Intensivos UMAE No. 1 Bajío]]></article-title>
<article-title xml:lang="en"><![CDATA[Relationship between the leukoglycemic index and multiple organ failure in septic patients in the ICU, UMAE No. 1 Bajio]]></article-title>
<article-title xml:lang="pt"><![CDATA[Associação do índice leuco-glicêmico com falência orgânica múltipla em pacientes sépticos na Unidade de Terapia Intensiva UMAE No. 1 Bajío]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Márquez Torres]]></surname>
<given-names><![CDATA[Claudia Berenice]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Bravo Santibañez]]></surname>
<given-names><![CDATA[Edgar]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Bocanegra Alegria]]></surname>
<given-names><![CDATA[Emiliano]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Instituto Mexicano del Seguro Social Hospital de Especialidades No. 1 Centro Médico Nacional Bajío Unidad Médica de Alta Especialidad]]></institution>
<addr-line><![CDATA[León Guanajuato]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2024</year>
</pub-date>
<volume>38</volume>
<numero>7</numero>
<fpage>594</fpage>
<lpage>599</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2448-89092024000700594&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2448-89092024000700594&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2448-89092024000700594&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Introducción:  el índice leucoglucémico (ILG) elevado (&gt; 2,000) se ha asociado con mal pronóstico en diversas áreas de cuidados intensivos. Sin embargo, se desconoce su valor pronóstico en pacientes sépticos y su relación con la falla orgánica múltiple (FOM). Este estudio busca determinar dicha relación en pacientes sépticos atendidos en la unidad de cuidados intensivos (UCI) de la UMAE No. 1 Bajío.  Objetivo:  determinar la relación entre el ILG y la FOM en pacientes sépticos en la UCI de la UMAE No. 1 Bajío.  Material y métodos:  se realizó un estudio transversal, retrospectivo y analítico en pacientes sépticos atendidos en la UCI de la UMAE No 1 Bajío. Se evaluaron los niveles de leucocitos y glucosa al ingreso para calcular el ILG, así como la evolución clínica de los pacientes (con o sin FOM). Se utilizaron pruebas t-Student o U de Mann-Whitney para comparar el ILG entre los grupos, y una regresión logística binaria para identificar los factores de riesgo asociados a la FOM, incluyendo la lesión renal aguda (LRA), el puntaje SOFA y otras variables clínicas.  Resultados:  de los 50 pacientes incluidos, 50% desarrollaron FOM. Aunque la mediana del ILG fue mayor en pacientes con FOM (1.91 vs 1.02), esta diferencia no fue estadísticamente significativa (p = 0.058). Sin embargo, los niveles de leucocitos fueron significativamente mayores en pacientes con FOM (p = 0.048). El análisis multivariable mostró que la LRA fue el principal factor de riesgo para desarrollar FOM (OR = 16.90, p = 0.029).  Conclusión:  aunque el ILG es un marcador potencial de riesgo, la LRA se identificó como el principal predictor de FOM, lo que sugiere la necesidad de integrar múltiples marcadores para optimizar la evaluación pronóstica en sepsis.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  Introduction:  an elevated leukoglycemic index (LGI) (&gt; 2,000) has been associated with poor prognosis in various intensive care settings. However, its prognostic value in septic patients and its relationship with multiple organ failure (MOF) is unknown. This study aims to determine this relationship in septic patients treated in the ICU of UMAE No. 1 Bajío.  Objective:  to determine the relationship between LGI and MOF in septic patients in the ICU of UMAE No. 1 Bajío.  Material and methods:  a cross-sectional, retrospective, and analytical study was conducted on septic patients treated in the ICU of UMAE No. 1 Bajío. Leukocyte and glucose levels at admission were evaluated to calculate the LGI, as well as the clinical evolution of the patients (with or without MOF). Student&#8217;s T-test or Mann-Whitney U test were used to compare LGI between groups, and binary logistic regression was used to identify risk factors associated with MOF, including acute kidney injury (AKI), SOFA score, and other clinical variables.  Results:  of the 50 patients included, 50% developed MOF. Although the median LGI was higher in patients with MOF (1.91 vs 1.02), this difference was not statistically significant (p = 0.058). However, leukocyte levels were significantly higher in patients with MOF (p = 0.048). Multivariable analysis showed that AKI was the main risk factor for developing MOF (OR = 16.90, p = 0.029).  Conclusion:  while LGI is a potential risk marker, AKI was identified as the main predictor of MOF, suggesting the need to integrate multiple markers to optimize prognostic evaluation in sepsis.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo:  Introdução:  um índice leucoglicémico (ILG) elevado (&gt; 2,000) tem sido associado a um mau prognóstico em várias áreas de cuidados intensivos. No entanto, seu valor prognóstico em pacientes sépticos e sua relação com a falência de múltiplos órgãos (FMO) são desconhecidos. Este estudo tem como objetivo determinar esta relação em pacientes sépticos tratados na UTI da UMAE No 1 Bajío.  Objetivo:  determinar a relação entre ILG e FMO em pacientes sépticos na UTI da UMAE No 1 Bajío.  Material e métodos:  foi realizado um estudo transversal, retrospetivo e analítico em pacientes sépticos atendidos na UTI da UMAE No 1 Bajío. Foram avaliados os níveis de leucócitos e de glucose na admissão para calcular o ILG, bem como a evolução clínica dos pacientes (com ou sem FMO). Os testes t de Student ou U de Mann-Whitney foram utilizados para comparar o ILG entre os grupos e a regressão logística binária foi utilizada para identificar os factores de risco associados à FMO, incluindo a lesão renal aguda (LRA), a pontuação SOFA e outras variáveis clínicas.  Resultados:  dos 50 pacientes incluídos, 50% desenvolveram FMO. Embora a mediana do ILG tenha sido maior nos pacientes com FMO (1.91 vs. 1.02), essa diferença não foi estatisticamente significativa (p = 0.058). No entanto, os níveis de leucócitos foram significativamente mais elevados nos doentes com FMO (p = 0.048). A análise multivariada mostrou que a LRA foi o principal fator de risco para o desenvolvimento de FMO (OR = 16.90, p = 0.029).  Conclusão:  embora o ILG seja um potencial marcador de risco, a LRA foi identificada como o principal preditor de FMO, sugerindo a necessidade de integrar múltiplos marcadores para otimizar a avaliação prognóstica na sépsis.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[relación]]></kwd>
<kwd lng="es"><![CDATA[Pearson]]></kwd>
<kwd lng="es"><![CDATA[leucocitos]]></kwd>
<kwd lng="es"><![CDATA[glicemia]]></kwd>
<kwd lng="es"><![CDATA[falla orgánica]]></kwd>
<kwd lng="en"><![CDATA[relationship]]></kwd>
<kwd lng="en"><![CDATA[Pearson]]></kwd>
<kwd lng="en"><![CDATA[leukocytes]]></kwd>
<kwd lng="en"><![CDATA[glycemic]]></kwd>
<kwd lng="en"><![CDATA[organ failure]]></kwd>
<kwd lng="pt"><![CDATA[relação]]></kwd>
<kwd lng="pt"><![CDATA[pearson]]></kwd>
<kwd lng="pt"><![CDATA[leucócitos]]></kwd>
<kwd lng="pt"><![CDATA[glicemia]]></kwd>
<kwd lng="pt"><![CDATA[falência de órgãos]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Singer]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Deutschman]]></surname>
<given-names><![CDATA[CS]]></given-names>
</name>
<name>
<surname><![CDATA[Seymour]]></surname>
<given-names><![CDATA[CW]]></given-names>
</name>
<name>
<surname><![CDATA[Shankar-Hari]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Annane]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Bauer]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Third International Consensus Definitions for sepsis and septic shock (sepsis-3)]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>2016</year>
<volume>315</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>801-10</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Seymour]]></surname>
<given-names><![CDATA[CW]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[VX]]></given-names>
</name>
<name>
<surname><![CDATA[Iwashyna]]></surname>
<given-names><![CDATA[TJ]]></given-names>
</name>
<name>
<surname><![CDATA[Brunkhorst]]></surname>
<given-names><![CDATA[FM]]></given-names>
</name>
<name>
<surname><![CDATA[Rea]]></surname>
<given-names><![CDATA[TD]]></given-names>
</name>
<name>
<surname><![CDATA[Scherag]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Assessment of clinical criteria for sepsis: for the Third International Consensus Definitions for sepsis and septic shock (sepsis-3)]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>2016</year>
<volume>315</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>762-74</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Neira-Sanchez]]></surname>
<given-names><![CDATA[ER]]></given-names>
</name>
<name>
<surname><![CDATA[Málaga]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sepsis-3 y las nuevas definiciones, ¿es tiempo de abandonar SIRS?]]></article-title>
<source><![CDATA[Acta Médica Peru]]></source>
<year>2016</year>
<volume>33</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>217-22</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cohen]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The immunopathogenesis of sepsis]]></article-title>
<source><![CDATA[Nature]]></source>
<year>2002</year>
<volume>420</volume>
<numero>6917</numero>
<issue>6917</issue>
<page-range>885-91</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Angus]]></surname>
<given-names><![CDATA[DC]]></given-names>
</name>
<name>
<surname><![CDATA[van der Poll]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Severe sepsis and septic shock]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2013</year>
<volume>369</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>840-51</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Guidet]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Aegerter]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Gauzit]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Meshaka]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Dreyfuss]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Incidence and impact of organ dysfunctions associated with sepsis]]></article-title>
<source><![CDATA[Chest]]></source>
<year>2005</year>
<volume>127</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>942-51</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carrillo-Esper]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Carrillo-Córdova]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
<name>
<surname><![CDATA[Carrillo-Córdova]]></surname>
<given-names><![CDATA[LD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estudio epidemiológico de la sepsis en unidades de terapia intensiva mexicanas]]></article-title>
<source><![CDATA[Cir Cir]]></source>
<year>2009</year>
<volume>77</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>301-8</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kaukonen]]></surname>
<given-names><![CDATA[KM]]></given-names>
</name>
<name>
<surname><![CDATA[Bailey]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Pilcher]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Cooper]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
<name>
<surname><![CDATA[Bellomo]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Systemic inflammatory response syndrome criteria in defining severe sepsis]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2015</year>
<volume>372</volume>
<numero>17</numero>
<issue>17</issue>
<page-range>1629-38</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mayr]]></surname>
<given-names><![CDATA[FB]]></given-names>
</name>
<name>
<surname><![CDATA[Yende]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Angus]]></surname>
<given-names><![CDATA[DC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiology of severe sepsis]]></article-title>
<source><![CDATA[Virulence]]></source>
<year>2014</year>
<volume>5</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>4-11</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Heled]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Fleischmann]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Epstein]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cytokines and their role in hyperthermia and heat stroke]]></article-title>
<source><![CDATA[J Basic Clin Physiol Pharmacol]]></source>
<year>2013</year>
<volume>24</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>85-96</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ratiani]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Gamkrelidze]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Khuchua]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Khutsishvili]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Intskirveli]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Vardosanidze]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Altered microcirculation in septic shock]]></article-title>
<source><![CDATA[Georgian Med News]]></source>
<year>2015</year>
<page-range>16-24</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="book">
<source><![CDATA[Salud y Medicina. La sepsis puede provocar fallo multiorgánico en pocas horas]]></source>
<year>2017</year>
<publisher-name><![CDATA[Saludymedicina.org]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Castro]]></surname>
<given-names><![CDATA[WA]]></given-names>
</name>
<name>
<surname><![CDATA[Conci]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Zelaya]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Isa]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Pacheco]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Sala]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estratificación del riesgo en el infarto agudo de miocardio según el índice leucoglucémico ¿El &#8220;Killip-Kimball&#8221; de laboratorio?]]></article-title>
<source><![CDATA[Rev Fed Arg Cardiol]]></source>
<year>2010</year>
<volume>39</volume>
<page-range>29-34</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sanjuán]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Núñez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Luisa-Blasco]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Miñana]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez-Maicas]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Carbonell]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prognostic implications of stress hyperglycemia in acute ST elevation myocardial infarction. Prospective observational study]]></article-title>
<source><![CDATA[Rev Esp Cardiol Engl Ed]]></source>
<year>2011</year>
<volume>64</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>201-7</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Qian]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Yan]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Zhao]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Che]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[Hiperglucemia al ingreso y pronóstico en pacientes con infarto agudo de miocardio]]></source>
<year>2023</year>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García-Álvarez]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[García-Albero]]></surname>
<given-names><![CDATA[ÁP]]></given-names>
</name>
<name>
<surname><![CDATA[Santana-Álvarez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Índice leuco glucémico como predictor a corto plazo de mortalidad en el ictus isquémico]]></article-title>
<source><![CDATA[Rev Arch Méd Camagüey]]></source>
<year>2018</year>
<volume>22</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>163-70</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hirschson-Prado]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Higa]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Merlo]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Dominé]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Blanco]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Vazquez]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Valor pronóstico del índice leucoglucémico en el infarto agudo de miocardio. Resultados del Registro Multicéntrico SCAR]]></article-title>
<source><![CDATA[Rev Argent Cardiol]]></source>
<year>2014</year>
<volume>82</volume>
<page-range>500-5</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Qi]]></surname>
<given-names><![CDATA[LY]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[HX]]></given-names>
</name>
<name>
<surname><![CDATA[Cheng]]></surname>
<given-names><![CDATA[LC]]></given-names>
</name>
<name>
<surname><![CDATA[Luo]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Yang]]></surname>
<given-names><![CDATA[SQ]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prognostic value of the leuko-glycemic index in acute myocardial infarction patients with or without diabetes]]></article-title>
<source><![CDATA[Diabetes Metab Syndr Obes]]></source>
<year>2022</year>
<volume>15</volume>
<page-range>1725-36</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodríguez-Jiménez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Fardales-Rodríguez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Toledo-Rodríguez]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Quintana-Cañizarez]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Índice leuco-glucémico como factor pronóstico tras un infarto agudo del miocardio con elevación del segmento ST]]></article-title>
<source><![CDATA[Rev Finlay]]></source>
<year>2019</year>
<volume>9</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>97-107</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Uchino]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Kellum]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Bellomo]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Doig]]></surname>
<given-names><![CDATA[GS]]></given-names>
</name>
<name>
<surname><![CDATA[Morimatsu]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Morgera]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Acute renal failure in critically ill patients: a multinational, multicenter study]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>2005</year>
<volume>294</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>813-8</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Asim]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Amin]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[El-Menyar]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Multiple organ dysfunction syndrome: Contemporary insights on the clinicopathological spectrum]]></article-title>
<source><![CDATA[Qatar Med J]]></source>
<year>2020</year>
<volume>2020</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[León-Aliz]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez-Fernández]]></surname>
<given-names><![CDATA[GA]]></given-names>
</name>
<name>
<surname><![CDATA[Moreno-Martínez]]></surname>
<given-names><![CDATA[FL]]></given-names>
</name>
<name>
<surname><![CDATA[Vega-Fleites]]></surname>
<given-names><![CDATA[LF]]></given-names>
</name>
<name>
<surname><![CDATA[Rabassa-López-Calleja]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Índice leuco-glucémico como marcador pronóstico de la evolución intrahospitalaria en pacientes con infarto agudo de miocardio con elevación del ST]]></article-title>
<source><![CDATA[Clín Invest Arterioscl]]></source>
<year>2014</year>
<volume>26</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>168-75</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
